Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia-Reference-Cited by-同舟云学术

Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia

Published:2018-02-16 Issue:10 Volume:128 Page:2234-2236
ISSN:0023-852X
Container-title:The Laryngoscope
language:en
Short-container-title:The Laryngoscope

Author:

Parambil Joseph G.¹^ORCID,Woodard Troy D.²,Koc Omer N.³

Affiliation:

1. Respiratory Institute, Cleveland Clinic; Cleveland Ohio U.S.A.

2. Head and Neck Institute, Cleveland Clinic; Cleveland Ohio U.S.A.

3. Taussig Cancer Institute; Cleveland Clinic; Cleveland Ohio U.S.A.

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lary.27129/fullpdf

Reference16 articles.

1. Hereditary hemorrhagic telangiectasia;Parambil;Clin Chest Med,2016

2. Transforming growth factor β family members in regulation of vascular function: in the light of vascular conditional knockouts;Jakobsson;Exp Cell Res,2013

3. Executive summary of the 11th HHT international scientific conference;Arthur;Angiogenesis,2015

4. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia;Faughnan;J Med Genet,2011

5. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression;Sadick;Haematologica,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Congenital Vascular and Lymphatic Diseases;Circulation Research;2024-06-21

2. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances;Journal of Clinical Investigation;2024-02-15

3. Psoriasis exudativa in patient with hereditary hemorrhagic telangiectasia;Russian Journal of Clinical Dermatology and Venereology;2024

4. Hereditary hemorrhagic telangiectasia (Osler‑Weber‑Rendu syndrome) - Part II. Pharmacological therapy and international guidelines for the therapy 2020;Vnitřní lékařství;2021-11-01

5. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia;Angiogenesis;2021-07-22